HbA1c at your finger tips!
Yes that’s what I literally mean in that you do not have to visit your favourite diagnostic centre or someone from a diagnostic centre visit you to draw a sample of your blood. The test can happen in the comfort of your house provided there is a refrigerator in the house which I assume is the case with most of the population out there and even if you don’t, feel free to approach your neighbour.
Metrics are everywhere and everyone wants to measure/track them. While we all understand that your blood glucose can be monitored any number of times in a given day using an ordinary Glucometer, the fact of the matter is that many of us don’t prick that often. Initial Euphoria or as I may call, anxiety when you are first diagnosed either with a type-1 or type-2 diabetes is always observed and the zeal to check using a Glucometer multiple times is seldom found as time passes. But yes, there are some dutiful diabetics and they are not our target audience unless they want to do some math.
What your HbA1c gadget does is to provide your result in exactly 5 minutes and all of the equipment has one code for all tests and it just needs some discipline with temperature. Once you have the results, do a comparison test against a diagnostics lab and we have a 99% match. Interesting right…
The moral of the story is that you now have a test right in your living room and can set goals as to how you want to toggle HbA1c between 7.0 and 6.5 which gives you an average for 3 months and is a testimony for, how well you are under control with your Glycemic levels. For more information on real user experiences email – firstname.lastname@example.org. More on the product shall be published onto the site www.docturnal.com (currently beta) once formally launched.
Tuberclosis(TB) being the infectious disease is communicated almost exclusively by coughed aerosols carrying pathogens of Mycobacterium tuberclosis (Mtb). As reported by World Health Organization (WHO) it causes disease in 9.6 millions people each year and ranks with human immunodeficiency virus (HIV) as a leading cause of disease. A well timed diagnosis and appropriate treatment can […]Read More »
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that […]Read More »
In a large epidemiologic study, researchers at UCLA’s Jonsson Cancer Center found that the children of U.S.-born Latina women are at higher risk of having retinoblastoma, a malignant tumor of the retina which typically occurs in children under six. The study, which focused on babies born in California, also found that offspring of older fathers […]Read More »
Since June 2012, it is official: The World Health Organisation (WHO) has classified diesel soot as a lung carcinogen. Artur Braun, a physicist at Empa and an X-ray spectroscopy expert, has made crucial contributions to analyzing the structure and composition of soot particles. Soot particles are dangerous – there is nothing new in this knowledge. […]Read More »
A new clinical trial published in the August edition of Clinical Cancer Research has revealed that cancer patients who drink one glass of grapefruit juice per day achieve the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself. It could also help […]Read More »
On 14 February 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with heart failure. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be […]Read More »
When combined with standard diagnostic tests, functional imaging procedures have been shown to reduce the rate of misdiagnosed cases of infectious endocarditis. According to new research published in the August issue of The Journal of Nuclear Medicine, single photon emission computed tomography (SPECT)/computed tomography (CT) with 99mTc-hexamethylpropleneamine oxime-labeled white blood cells (99mTc-HMPAO-WBC) can improve the […]Read More »
For years, scientists have been looking for a good source of heart cells that can be used to study cardiac function in the lab, or perhaps even to replace diseased or damaged tissue in heart disease patients. To do this, many are looking to stem cells. Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Human […]Read More »
A new genetic analysis focusing on Jews from North Africa has provided an overall genetic map of the Jewish Diasporas. The findings support the historical record of Middle Eastern Jews settling in North Africa during Classical Antiquity, proselytizing and marrying local populations, and, in the process, forming distinct populations that stayed largely intact for more […]Read More »
University of Minnesota School of Public Health researchers have found that medical group practices can reduce costs for patients with diabetes by investing in improved quality of care. In the study, which appears in the August issue of Health Affairs, University of Minnesota researchers analyzed 234 medical group practices providing care for more than 133,000 […]Read More »